Cylex Inc

Cylex Inc. is a global life science company based in Columbia, Maryland, with 22 employees. Cylex develops and manufactures research and in vitro diagnostic products focused on understanding immunity. Their flagship product, ImmuKnow, is an FDA-cleared in vitro diagnostic tool used to detect cell-mediated immunity in immunosuppressed populations. This product allows clinical researchers to measure immune cell function in a simple and reproducible manner. Cylex holds ISO 13485:2003 and ISO 9001:2000 certifications, signifying compliance with internationally recognized standards for medical product design, development, and manufacturing. The company also possesses a method patent issued in 1998 for measuring T-cell activation, stemming from research funded by the Department of Defense. Their patent portfolio includes patents in the United States, Australia, and pending patents in Europe, Canada, and Japan. Cylex Inc. can be contacted via their website at cylex.net.